Aveanna Healthcare (AVAH)

• Market cap: $1.69B
• 1 day: -1.82%
• 5 days: -2.06%
• 1 month: 14.77%
• 3 months: 67.29%
• 6 months: 46.64%
• Year to date: 79.16%
• 1 year: 52.74%
• 5 years: -29.92%
• 10 years: -29.92%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

Employees: 33,500

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

120% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 15

96% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 27

20% more funds holding in top 10

Funds holding in top 10: 5 [Q1] → 6 (+1) [Q2]

16% more funds holding

Funds holding: 115 [Q1] → 133 (+18) [Q2]

5.81% more ownership

Funds ownership: 89.14% [Q1] → 94.95% (+5.81%) [Q2]

3% more capital invested

Capital invested by funds: $943M [Q1] → $969M (+$26.2M) [Q2]

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $5K

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $5
• Avg. target: $7.5
• High target: $9.5

5 analyst ratings

• positive: 3 60%
• neutral: 2 40%
• negative: 0 0%

UBS A.J. Rice	$8	Neutral Upgraded	19 Aug 2025
Barclays Andrew Mok	$9.5	Overweight Upgraded	19 Aug 2025
Raymond James John Ransom	$9	Outperform Upgraded	11 Aug 2025
Jefferies Brian Tanquilut	$6	Buy Upgraded	21 Jul 2025
Truist Securities David Macdonald	$5	Hold Maintained	16 Jul 2025